pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
ADCED-01
Soft Tissue Sarcoma
ADCendo ApS
0
catalysts
Phase 1
ADCT-701
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Chiome Bioscience Inc
0
catalysts
Phase 2
ADG-116
Solid Tumor
$ADAG
Adagene Inc.
0
catalysts
Preclinical
ADI-002
Solid Tumor
← prev
page 51 of 271
next →
131
Pain
89
Neurology
1
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Preclinical
ADI-100
Type 1 Diabetes (Juvenile Diabetes)
$ADTX
Aditxt, Inc.
0
catalysts
Preclinical
ADI-212
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$ACET
Adicet Bio, Inc.
0
catalysts
Preclinical
ADP-2
Triple-Negative Breast Cancer (TNBC)
Adecto Pharmaceuticals Inc
0
catalysts
ADQUEY
ADQUEY (DIFAMILAST)
Acrotech Biopharma Inc
0
catalysts
ADRENALIN (EPINEPHRINE IN SODIUM CHLORIDE)
ADRENALIN (EPINEPHRINE IN SODIUM CHLORIDE) (EPINEPHRINE IN SODIUM CHLORIDE)
PH HEALTH
0
catalysts
Phase 1
ADRX-0405
Gastric Cancer
Adcentrx Therapeutics Inc
0
catalysts
Phase 1
ADRX-0706
Cervical Cancer
Adcentrx Therapeutics Inc
0
catalysts
Phase 1
ADU-1805
Solid Tumor
Sairopa BV
0
catalysts
ADVAIR HFA
ADVAIR HFA (FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE)
GLAXO GRP LTD
0
catalysts
Phase 1
AFA-281
Inflammatory Pain
AfaSci Inc
0
catalysts
Phase 2
AFM-24I
Breast Cancer
Affimed GmbH
0
catalysts
AFREZZA
AFREZZA (INSULIN RECOMBINANT HUMAN)
1 INDICATIONS AND USAGE AFREZZA ® is indicated to improve glycemic control in…
Insulin receptor
$MNKD
MANNKIND CORP
0
catalysts
Phase 2
AFTX-201
Dilated Cardiomyopathy
Affinia Therapeutics Inc
0
catalysts
Phase 1
AG-236
Polycythemia Vera
$AGIO
AGIOS PHARMACEUTICALS, INC.
0
catalysts
Preclinical
AG-73305
Retinal Vein Occlusion
Allgenesis Biotherapeutics Inc
0
catalysts
Phase 2
AGA-2115
Osteogenesis Imperfecta
Angitia Biopharmaceuticals Ltd
0
catalysts
Preclinical
AGB-473
Mild Cognitive Impairment
AgeneBio Inc
0
catalysts
Phase 1
AGEN-1571
Solid Tumor
$AGEN
AGENUS INC
0
catalysts
Phase 1
AGEN-1777
Colon Cancer
$AGEN
AGENUS INC
0
catalysts
Phase 1
AGEN-2373
Adrenal Gland Cancer
$AGEN
AGENUS INC
0
catalysts
Phase 2
AGLE-102
Burns
Aegle Therapeutics Corp
0
catalysts
Preclinical
AGN-001
Retinitis Pigmentosa (Retinitis)
Agnos Therapeutics Inc
0
catalysts
Preclinical
AGR-101
Seizures
Agrithera Inc
0
catalysts
Preclinical
AGS-499
Amyotrophic Lateral Sclerosis
Neuromagen Pharma Ltd
0
catalysts
Phase 2
AGT-100216
Charcot-Marie-Tooth Disease Type I A
Augustine Therapeutics NV
0
catalysts
Preclinical
AGT-104T
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Addimmune
0
catalysts
